Monthly
US$200
Billed every month
生理氯化钠溶液
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 2 applicationsAccepted: 3 applicationsNo longer listed under review: 1 applicationSupplement delivery: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders0View records ↓
Under-review filings17View records ↓
This year’s generic filers3View records ↓
NHSA approval numbers68View records ↓
API companies with A status0View records ↓
Chemical-drug catalogue
Loaded records: 0 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 68 distinct approval numbers and 36 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 安徽双鹤药业有限责任公司 | 国药准字H20054037 | 500ml | Not stated by source | XB05CBS079B001010104346 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H20023299 | 2000ml:18g | Category B (乙) | XB05CBS079S002010100144 | NHSA |
| 广东大冢制药有限公司 | 国药准字H44020191 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010100273 | NHSA |
| 上海百特医疗用品有限公司 | 国药准字H20013250 | 0.9% | Category B (乙) | XB05CBS079S002010100628 | NHSA |
| 中国大冢制药有限公司 | 国药准字H12020026 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010100967 | NHSA |
| 辽宁民康制药有限公司 | 国药准字H20249095 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010101227 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20123407 | 1000ml:9g | Category B (乙) | XB05CBS079S002010102180 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20254328 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010102292 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20058664 | 1000ml:9g | Category B (乙) | XB05CBS079S002010102492 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20143081 | 3000ml:27g | Category B (乙) | XB05CBS079S002010102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083594 | 1000ml:9g | Category B (乙) | XB05CBS079S002010102763 | NHSA |
| 洛阳市制药厂 | 国药准字H20103391 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010103153 | NHSA |
| 兰西哈三联制药有限公司 | 国药准字H20183173 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010103662 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20255655 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010103758 | NHSA |
| 青州尧王制药有限公司 | 国药准字H20073635 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010104058 | NHSA |
| 广西裕源药业有限公司 | 国药准字H20065313 | 500ml:氯化钠4.5g | Category B (乙) | XB05CBS079S002010104075 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20103632 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010104098 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002010104145 | NHSA |
| 山东威高药业股份有限公司 | 国药准字H20066379 | 500ml | Category B (乙) | XB05CBS079S002010104177 | NHSA |
| 安徽丰原药业股份有限公司 | 国药准字H20247033 | 2000ml:18g | Category B (乙) | XB05CBS079S002010104286 | NHSA |
| 安徽双鹤药业有限责任公司 | 国药准字H20054037 | 500ml | Category B (乙) | XB05CBS079S002010104346 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20045346 | 1000ml:9g | Category B (乙) | XB05CBS079S002010104653 | NHSA |
| 浙江都邦药业股份有限公司 | 国药准字H20173274 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010104688 | NHSA |
| 浙江莎普爱思药业股份有限公司 | 国药准字H20073903 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010104693 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20073148 | 3000ml:27g氯化钠 | Category B (乙) | XB05CBS079S002010104718 | NHSA |
| 浙江康吉尔药业有限公司 | 国药准字H20143039 | 1000ml:9g | Category B (乙) | XB05CBS079S002010104745 | NHSA |
| 湖南金健药业有限责任公司 | 国药准字H20066676 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010104936 | NHSA |
| 湖南康源制药有限公司 | 国药准字H20084580 | 3000ml:27g | Category B (乙) | XB05CBS079S002010104947 | NHSA |
| 回音必集团江西东亚制药有限公司 | 国药准字H36022044 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010105251 | NHSA |
| 吉林省都邦药业股份有限公司 | 国药准字H20249694 | 3000ml:27g | Category B (乙) | XB05CBS079S002010109517 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113369 | 1000ml:9g | Category B (乙) | XB05CBS079S002010109581 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20254067 | 500ml∶4.5g | Category B (乙) | XB05CBS079S002010109910 | NHSA |
| 河北道恩药业有限公司 | 国药准字H20263095 | 100ml:0.9g | Category B (乙) | XB05CBS079S002010181073 | NHSA |
| 北京柏雅联合药物研究所有限公司 | 国药准字H20253140 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010183184 | NHSA |
| 山东科伦药业有限公司 | 国药准字H20253747 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010183221 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20123407 | 1000ml:9g | Category B (乙) | XB05CBS079S002010202180 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20254328 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010202292 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083594 | 1000ml:9g | Category B (乙) | XB05CBS079S002010202763 | NHSA |
| 华仁药业股份有限公司 | 国药准字H20034093 | 3000ml:27g | Category B (乙) | XB05CBS079S002010204042 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20103632 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010204098 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002010204145 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20045346 | 1000ml:9g | Category B (乙) | XB05CBS079S002010204653 | NHSA |
| 回音必集团江西东亚制药有限公司 | 国药准字H36022044 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010205251 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113369 | 1000ml:9g | Category B (乙) | XB05CBS079S002010209581 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20254067 | 500ml∶4.5g | Category B (乙) | XB05CBS079S002010209910 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083594 | 1000ml:9g | Category B (乙) | XB05CBS079S002010302763 | NHSA |
| 华仁药业股份有限公司 | 国药准字H20034093 | 3000ml:27g | Category B (乙) | XB05CBS079S002010304042 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20103632 | 500ml:4.5g | Category B (乙) | XB05CBS079S002010304098 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002010304145 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20045346 | 1000ml:9g | Category B (乙) | XB05CBS079S002010304653 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113369 | 1000ml:9g | Category B (乙) | XB05CBS079S002010309581 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083594 | 1000ml:9g | Category B (乙) | XB05CBS079S002010402763 | NHSA |
| 华仁药业股份有限公司 | 国药准字H20034093 | 3000ml:27g | Category B (乙) | XB05CBS079S002010404042 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113369 | 1000ml:9g | Category B (乙) | XB05CBS079S002010409581 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083594 | 1000ml:9g | Category B (乙) | XB05CBS079S002010502763 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H20023300 | 3000ml:27g | Category B (乙) | XB05CBS079S002020100144 | NHSA |
| 广东大冢制药有限公司 | 国药准字H20227033 | 50ml:0.45g | Category B (乙) | XB05CBS079S002020100273 | NHSA |
| 上海百特医疗用品有限公司 | 国药准字H20013250 | 0.9% | Category B (乙) | XB05CBS079S002020100628 | NHSA |
| 辽宁民康制药有限公司 | 国药准字H20249094 | 100ml:0.9g | Category B (乙) | XB05CBS079S002020101227 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20123408 | 2000ml:18g | Category B (乙) | XB05CBS079S002020102180 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20254329 | 3000ml:27g | Category B (乙) | XB05CBS079S002020102292 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20058667 | 100ml:0.9g | Category B (乙) | XB05CBS079S002020102492 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20103742 | 500ml:4.5g | Category B (乙) | XB05CBS079S002020102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083576 | 2000ml:18g | Category B (乙) | XB05CBS079S002020102763 | NHSA |
| 华仁药业股份有限公司 | 国药准字H20034093 | 3000ml:27g | Category B (乙) | XB05CBS079S002020104042 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002020104145 | NHSA |
| 安徽丰原药业股份有限公司 | 国药准字H20247034 | 3000ml:27g | Category B (乙) | XB05CBS079S002020104286 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20045345 | 2000ml:18g | Category B (乙) | XB05CBS079S002020104653 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20055509 | 500ml:4.5g氯化钠 | Category B (乙) | XB05CBS079S002020104718 | NHSA |
| 湖南康源制药有限公司 | 国药准字H20103070 | 500ml:4.5g | Category B (乙) | XB05CBS079S002020104947 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113370 | 3000ml:27g | Category B (乙) | XB05CBS079S002020109581 | NHSA |
| 河北道恩药业有限公司 | 国药准字H20263096 | 500ml:4.5g | Category B (乙) | XB05CBS079S002020181073 | NHSA |
| 山东科伦药业有限公司 | 国药准字H20253748 | 3000ml:27g | Category B (乙) | XB05CBS079S002020183221 | NHSA |
| 辽宁民康制药有限公司 | 国药准字H20249094 | 100ml:0.9g | Category B (乙) | XB05CBS079S002020201227 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20123408 | 2000ml:18g | Category B (乙) | XB05CBS079S002020202180 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20058667 | 100ml:0.9g | Category B (乙) | XB05CBS079S002020202492 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20103742 | 500ml:4.5g | Category B (乙) | XB05CBS079S002020202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083576 | 2000ml:18g | Category B (乙) | XB05CBS079S002020202763 | NHSA |
| 华仁药业股份有限公司 | 国药准字H20034093 | 3000ml:27g | Category B (乙) | XB05CBS079S002020204042 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002020204145 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20045345 | 2000ml:18g | Category B (乙) | XB05CBS079S002020204653 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113370 | 3000ml:27g | Category B (乙) | XB05CBS079S002020209581 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083576 | 2000ml:18g | Category B (乙) | XB05CBS079S002020302763 | NHSA |
| 华仁药业股份有限公司 | 国药准字H20034093 | 3000ml:27g | Category B (乙) | XB05CBS079S002020304042 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20045345 | 2000ml:18g | Category B (乙) | XB05CBS079S002020304653 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113370 | 3000ml:27g | Category B (乙) | XB05CBS079S002020309581 | NHSA |
| 石家庄四药有限公司 | 国药准字H20083576 | 2000ml:18g | Category B (乙) | XB05CBS079S002020402763 | NHSA |
| 华仁药业股份有限公司 | 国药准字H20034093 | 3000ml:27g | Category B (乙) | XB05CBS079S002020404042 | NHSA |
| 广东大冢制药有限公司 | 国药准字H20227032 | 100ml:0.9g | Category B (乙) | XB05CBS079S002030100273 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20123409 | 3000ml:27g | Category B (乙) | XB05CBS079S002030102180 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20058666 | 2000ml:18g | Category B (乙) | XB05CBS079S002030102492 | NHSA |
| 石家庄四药有限公司 | 国药准字H20133355 | 3000ml:27g | Category B (乙) | XB05CBS079S002030102763 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002030104145 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20046424 | 3000ml:27g | Category B (乙) | XB05CBS079S002030104653 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20055510 | 1000ml:9g氯化钠 | Category B (乙) | XB05CBS079S002030104718 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113368 | 500ml:4.5g | Category B (乙) | XB05CBS079S002030109581 | NHSA |
| 河北道恩药业有限公司 | 国药准字H20263098 | 2000ml:18g | Category B (乙) | XB05CBS079S002030181073 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20123409 | 3000ml:27g | Category B (乙) | XB05CBS079S002030202180 | NHSA |
| 石家庄四药有限公司 | 国药准字H20133355 | 3000ml:27g | Category B (乙) | XB05CBS079S002030202763 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002030204145 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20046424 | 3000ml:27g | Category B (乙) | XB05CBS079S002030204653 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20055510 | 1000ml:9g氯化钠 | Category B (乙) | XB05CBS079S002030204718 | NHSA |
| 石家庄四药有限公司 | 国药准字H20133355 | 3000ml:27g | Category B (乙) | XB05CBS079S002030302763 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002030304145 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20046424 | 3000ml:27g | Category B (乙) | XB05CBS079S002030304653 | NHSA |
| 广东大冢制药有限公司 | 国药准字H20227031 | 250ml:2.25g | Category B (乙) | XB05CBS079S002040100273 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20083400 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040102180 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20058668 | 250ml:2.25g | Category B (乙) | XB05CBS079S002040102492 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040102763 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20113297 | 500ml:4.5g;1000ml:9g;2000ml:18g;3000ml:27g | Category B (乙) | XB05CBS079S002040104145 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20023157 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040104653 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113369 | 1000ml:9g | Category B (乙) | XB05CBS079S002040109581 | NHSA |
| 河北道恩药业有限公司 | 国药准字H20263099 | 3000ml:27g | Category B (乙) | XB05CBS079S002040181073 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20058668 | 250ml:2.25g | Category B (乙) | XB05CBS079S002040202492 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040202763 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20023157 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040204653 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040302763 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20023157 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040304653 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040402763 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20023157 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040404653 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040502763 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040602763 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040702763 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040802763 | NHSA |
| 石家庄四药有限公司 | 国药准字H20066533 | 500ml:4.5g | Category B (乙) | XB05CBS079S002040902763 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20058665 | 3000ml:27g | Category B (乙) | XB05CBS079S002050102492 | NHSA |
| 济民健康管理股份有限公司 | 国药准字H20023157 | 500ml:4.5g | Category B (乙) | XB05CBS079S002050104653 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113370 | 3000ml:27g | Category B (乙) | XB05CBS079S002050109581 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20113370 | 3000ml:27g | Category B (乙) | XB05CBS079S002050209581 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20059041 | 500ml:4.5g | Category B (乙) | XB05CBS079S002060102492 | NHSA |
| 西安京西双鹤药业有限公司 | 国药准字H20059041 | 500ml:4.5g | Category B (乙) | XB05CBS079S002060202492 | NHSA |
| 广东科伦药业有限公司 | 国药准字H20046295 | 1000ml:9g | Category B (乙) | XB05CBS079W008010100318 | NHSA |
| 安徽丰原药业股份有限公司 | 国药准字H20103227 | 500ml:4.5g | Category B (乙) | XB05CBS079W008010104286 | NHSA |
| 广东科伦药业有限公司 | 国药准字H20046295 | 1000ml:9g | Category B (乙) | XB05CBS079W008010200318 | NHSA |
| 广东科伦药业有限公司 | 国药准字H20046295 | 1000ml:9g | Category B (乙) | XB05CBS079W008020100318 | NHSA |
| 广东科伦药业有限公司 | 国药准字H20046295 | 1000ml:9g | Category B (乙) | XB05CBS079W008020200318 | NHSA |
| 广东科伦药业有限公司 | 国药准字H20046295 | 1000ml:9g | Category B (乙) | XB05CBS079W008030100318 | NHSA |
| 广东科伦药业有限公司 | 国药准字H20046295 | 1000ml:9g | Category B (乙) | XB05CBS079W008030200318 | NHSA |
| 广东科伦药业有限公司 | 国药准字H20046295 | 1000ml:9g | Category B (乙) | XB05CBS079W008040100318 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 17 filings and 12 distinct first applicants.
Supplement 5 · Generic 12
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 西安京西双鹤药业有限公司 | CYHB2601771 | Supplement | 2026/09/21 | Not stated by source | CDE |
| 河北广祥医药科技有限公司;石家庄四药有限公司 | CYHS2602085 | Generic | 2026/08/21 | Not stated by source | CDE |
| 石药银湖制药有限公司 | CYHS2602082 | Generic | 2026/08/21 | Not stated by source | CDE |
| 河北广祥医药科技有限公司;石家庄四药有限公司 | CYHS2601979 | Generic | 2026/08/12 | Not stated by source | CDE |
| 安徽双鹤药业有限责任公司 | CYHB2601159 | Supplement | 2026/06/22 | Not stated by source | CDE |
| 华仁药业股份有限公司 | CYHB2601092 | Supplement | 2026/06/10 | Not stated by source | CDE |
| 华仁药业股份有限公司 | CYHB2601091 | Supplement | 2026/06/10 | Not stated by source | CDE |
| 广东科泓药业有限公司 | CYHB2601029 | Supplement | 2026/05/29 | Not stated by source | CDE |
| 河北广祥医药科技有限公司;石家庄四药有限公司 | CYHS2601054 | Generic | 2026/05/08 | Not stated by source | CDE |
| 华仁药业（日照）有限公司 | CYHS2600110 | Generic | 2026/01/09 | Not stated by source | CDE |
| 上海长征富民金山制药有限公司 | CYHS2504148 | Generic | 2025/12/03 | Not stated by source | CDE |
| 上海长征富民金山制药有限公司 | CYHS2504147 | Generic | 2025/12/03 | Not stated by source | CDE |
| 哈尔滨三联药业股份有限公司 | CYHS2503357 | Generic | 2025/09/10 | Not stated by source | CDE |
| 哈尔滨三联药业股份有限公司;兰西哈三联制药有限公司 | CYHS2503355 | Generic | 2025/09/10 | Not stated by source | CDE |
| 山东华茂药业有限公司 | CYHS2502610 | Generic | 2025/07/19 | Not stated by source | CDE |
| 四川青山利康药业有限公司 | CYHS2502453 | Generic | 2025/07/09 | Not stated by source | CDE |
| 浙江赛默制药有限公司 | CYHS2501720 | Generic | 2025/05/13 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 5 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 河北广祥医药科技有限公司;石家庄四药有限公司 | CYHS2602085 | Generic | 2026/08/21 | Not stated by source | CDE |
| 石药银湖制药有限公司 | CYHS2602082 | Generic | 2026/08/21 | Not stated by source | CDE |
| 河北广祥医药科技有限公司;石家庄四药有限公司 | CYHS2601979 | Generic | 2026/08/12 | Not stated by source | CDE |
| 河北广祥医药科技有限公司;石家庄四药有限公司 | CYHS2601054 | Generic | 2026/05/08 | Not stated by source | CDE |
| 华仁药业（日照）有限公司 | CYHS2600110 | Generic | 2026/01/09 | Not stated by source | CDE |
API registrations
Non-component matches: 0 companies with A status and 0 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/03Marketing application approved
海南爱科制药有限公司
CYHS2500484 · 国药准字H20266426
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 22 ↗ -
2026/11/03Marketing application approved
海南爱科制药有限公司
CYHS2500483 · 国药准字H20266425
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 21 ↗ -
2026/10/23No longer listed under review
华润双鹤药业股份有限公司
CYHB2601464
Fact date: 2026/10/23 · Site observation date: 2026/10/23
Accepted: 2026/07/30
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 19
NMPA · Table row 19 ↗ View source ↗ -
2026/10/21Supplement delivery
华润双鹤药业股份有限公司
CYHB2601464
Fact date: 2026/10/21 · Publication date: 2026/10/23 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 19 ↗ -
2026/09/21Accepted
-
2026/08/21Accepted
河北广祥医药科技有限公司;石家庄四药有限公司
CYHS2602085
Fact date: 2026/08/21 · Site observation date: 2026/10/22
View source ↗ -
2026/08/21Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to this drug
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy